Higher Adherence During Reimbursement of Pharmacological Smoking Cessation Treatments

Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco
Job F M van Boven, Pepijn Vemer

Abstract

In the Netherlands, pharmacologic Smoking Cessation Treatments (pSCTs) were reimbursed in 2011. In 2012 the reimbursement was discontinued. As of 2013, pSCTs were again reimbursed, provided they are accompanied by behavioral counseling. The aim of this article is to assess the impact of changes in reimbursement policy on use of-and adherence to-pSCTs. A retrospective dispensing database analysis was performed on real-world observational data (2010-2013) from the Netherlands. Data on use and adherence was collected, in patients who were dispensed bupropion or varenicline in community pharmacies for the first time. Using the InterActionDataBase (iadb.nl), adherence per patient that initiated varenicline or bupropion was calculated by adding up all dispenses between initiation of the therapy and the 120 days thereafter. Good adherence was defined as using minimal 80% of the recommended duration and intensity of use. The prevalence of patients initiating pSCTs was stable at 0.4 per 1000 inhabitants per quarter during 2010. In 2011, the prevalence was on average 0.7, with peaks in the first (0.8 per 1000) and fourth (1.0 per 1000) quarters of 2011. In 2012, the prevalence was stable again at 0.3. In 2013, prevalence was on average 0...Continue Reading

References

Jun 17, 2005·Journal of Behavioral Medicine·Joy M SchmitzMarc E Mooney
Oct 20, 2006·Health Policy·Pieter H M van BaalTalitha L Feenstra
Jun 5, 2008·Tobacco Control·F-C ChangK-Y Chao
Jun 27, 2008·Research and Theory for Nursing Practice·Todd M RupparCynthia L Russell
Aug 9, 2008·International Journal of Chronic Obstructive Pulmonary Disease·Fernando Müller, Luis Wehbe
Feb 11, 2009·Archives of Internal Medicine·Hans Joachim SalizeHermann Brenner
Jun 17, 2009·Expert Review of Pharmacoeconomics & Outcomes Research·Joseph MenzinJeno Marton
Oct 7, 2009·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Pepijn Vemer, Maureen P M H Rutten-van Mölken
Jan 27, 2010·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Beth C BockFrederick R Bock
May 12, 2010·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·J Taylor HaysTheodore C Lee
Aug 6, 2010·Thorax·Martine HoogendoornMaureen P M H Rutten-van Mölken
Dec 15, 2010·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·James BalmfordK Michael Cummings
Feb 26, 2011·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Sheryl L CatzGary E Swan
Apr 12, 2011·CNS Drugs·Tobias Raupach, Constant P van Schayck
Mar 1, 2012·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Taneisha S BuchananNicole L Nollen
Feb 14, 2013·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Eva NohlertPia Johansson
Mar 7, 2013·Journal of Managed Care Pharmacy : JMCP·Joshua N LibermanH Lester Kirchner
Apr 12, 2013·Journal of Bone and Mineral Metabolism·Job F M van BovenStefan Vegter
Jun 15, 2013·Expert Review of Pharmacoeconomics & Outcomes Research·Sipke T VisserMaarten J Postma
Nov 1, 2013·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Beth C BockRaymond Niaura
Nov 22, 2013·The Annals of Pharmacotherapy·Ada G G Stuurman-BiezeStefan Vegter
Feb 27, 2014·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·A G G Stuurman-BiezeS Vegter

❮ Previous
Next ❯

Citations

Nov 12, 2016·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Amanda L GrahamDavid B Abrams
Feb 3, 2018·Irish Journal of Medical Science·Jackie O'Dwyer, Aileen Murphy
May 8, 2021·International Journal of Chronic Obstructive Pulmonary Disease·Rui QinChen Wang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
Job F M van Boven, Pepijn Vemer
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række
Werner Frøynes, Jan Schjøtt
BMJ : British Medical Journal
Mira Harrison-Woolrych
The American Journal of Psychiatry
A E Evins, T Tisdale
© 2021 Meta ULC. All rights reserved